Nexalin Technology, Inc. Increase Decrease In Operating Lease Liability
Nexalin Technology, Inc. (NXL) reported Increase Decrease In Operating Lease Liability of -$4.46 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-03-25
- Nexalin Technology, Inc. increase decrease in operating lease liability for the quarter ending 2024-12-31 was $0.00.
- Nexalin Technology, Inc. increase decrease in operating lease liability for the quarter ending 2024-09-30 was $0.00.
- Nexalin Technology, Inc. increase decrease in operating lease liability for the quarter ending 2024-06-30 was $0.00.
- Nexalin Technology, Inc. increase decrease in operating lease liability for the quarter ending 2024-03-31 was -$4.46K.
- Nexalin Technology, Inc. increase decrease in operating lease liability for fiscal 2024 was -$4.46K.
- Nexalin Technology, Inc. increase decrease in operating lease liability for fiscal 2023 was -$50.80K.
- Nexalin Technology, Inc. increase decrease in operating lease liability for fiscal 2022 was -$46.03K.
- Nexalin Technology, Inc. increase decrease in operating lease liability for fiscal 2021 was -$36.97K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | -$4.46K 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | -$4.46K 10-Q · filed 2025-11-14 | -$17.64K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$4.46K 10-Q · filed 2025-08-06 | -$17.64K derived: sum of 3 quarters · filed 2025-09-23 | -$30.49K derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-03-31 | -$4.46K 10-Q · filed 2025-05-13 | -$17.64K derived: sum of 2 quarters · filed 2025-09-23 | -$30.49K derived: sum of 3 quarters · filed 2025-09-23 | -$43.03K derived: sum of 4 quarters · filed 2025-09-23 |
| 2023-12-31 | -$13.17K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23 | -$26.02K derived: sum of 2 quarters · filed 2025-09-23 | -$38.56K derived: sum of 3 quarters · filed 2025-09-23 | -$50.80K 10-K/A · filed 2025-09-23 |
| 2023-09-30 | -$12.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$25.39K derived: sum of 2 quarters · filed 2024-11-08 | -$37.63K 10-Q · filed 2024-11-08 | -$49.56K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$12.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$24.77K 10-Q · filed 2024-08-08 | -$36.71K derived: sum of 3 quarters · filed 2024-08-08 | -$48.36K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$12.23K 10-Q · filed 2024-05-10 | -$24.17K derived: sum of 2 quarters · filed 2024-05-10 | -$35.82K derived: sum of 3 quarters · filed 2024-05-10 | -$47.18K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$11.94K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$23.58K derived: sum of 2 quarters · filed 2024-03-27 | -$34.95K derived: sum of 3 quarters · filed 2024-03-27 | -$46.03K 10-K · filed 2024-03-27 |
| 2022-09-30 | -$11.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$23.01K derived: sum of 2 quarters · filed 2023-11-13 | -$34.10K 10-Q · filed 2023-11-13 | -$43.69K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$11.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$22.45K 10-Q · filed 2023-08-10 | -$32.04K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$11.09K 10-Q · filed 2023-05-10 | -$20.68K derived: sum of 2 quarters · filed 2023-05-10 | ||
| 2021-12-31 | -$9.59K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$36.97K 10-K · filed 2023-03-27 | ||
| 2021-09-30 | -$27.38K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |